Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Anlotinib In Combination With Durvalumab
Start Date
April 1, 2020
Primary Completion Date
February 1, 2021
Completion Date
February 1, 2022
Last Updated
March 19, 2020
NCT05692635
NCT07485114
NCT07190248
NCT06305754
NCT06066138
NCT04253964
Lead Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions